TrianglePUBLICATIONS · 19536890
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2009 Aug 15
- First author
- Higano CS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Higano CS
- type
- Author
- name
- Schellhammer PF
- type
- Author
- name
- Small EJ
- type
- Author
- name
- Burch PA
- type
- Author
- name
- Nemunaitis J
- type
- Author
- name
- Yuh L
- type
- Author
- name
- Provost N
- type
- Author
- name
- Frohlich MW
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Higano CS
- type
- Author
- name
- Schellhammer PF
- type
- Author
- name
- Small EJ
- type
- Author
- name
- Burch PA
- type
- Author
- name
- Nemunaitis J
- type
- Author
- name
- Yuh L
- type
- Author
- name
- Provost N
- type
- Author
- name
- Frohlich MW
- type
- Author
- bibliography ids
- nci-bib-188c6093484f2ba0b800fcfd
- book metadata
- content sha256
- d3dad5628d0d7612896fc201a0db440d2d9cebc2674b59f261c3df8afac0d955
- document type
- citation
- dois
- 10.1002/cncr.24429
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19536890
- immutable id
- pubmed:19536890@d3dad5628d0d7612896fc201a0db440d2d9cebc2674b59f261c3df8afac0d955
- journal
- abbreviation
- Cancer
- issn electronic
- Source null
- issn print
- 0008-543X
- issue
- 16
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 3670-9
- volume
- 115
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19536890
- provenance
- batch id
- 4f803f1a8e7b4f56d2f1
- provider
- NCBI PubMed ESummary
- record sha256
- e0c4cb04a3da3cb98e2648f967b7f6814c25c37881371b4f11a65e2fc5eed496
- response sha256
- fddd7745d591ed24e15d20ce21f0a6c14874b8cee29153ff89c9892037c40127
- retrieved at
- 2026-09-09T23:46:26.391289+00:00
- publication date
- display
- 2009 Aug 15
- precision
- day
- year
- 2009
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.
Preserved source evidence · Not medical advice